CAGE Bio Starts Trial of DNA Aptamer CGB-600 for Vitiligo
24 Oct 2025 //
PR NEWSWIRE
CAGE Bio, Partner to Advance GvHD Cutaneous Treatments
27 Aug 2025 //
PR NEWSWIRE
CAGE Bio Initiates Phase 2 Study for Treatment of Rosacea
11 May 2021 //
PRNEWSWIRE

Market Place
Sourcing Support